MeSH term
Frequency | Condition_Probility | Base Sequence | 8 | 0.0 |
Cell Line | 5 | 0.0 |
DNA Primers | 3 | 0.0 |
*Gene Expression Regulation | 4 | 0.0 |
Humans | 69 | 0.0 |
Intestinal Mucosa/physiology | 2 | 18.0 |
Molecular Sequence Data | 13 | 0.0 |
*Mucins | 35 | 50.0 |
*Muscle Proteins | 49 | 16.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
*Neuropeptides | 49 | 39.0 |
Peptides/analysis/*genetics | 2 | 50.0 |
Polymerase Chain Reaction | 5 | 0.0 |
*Promoter Regions (Genetics) | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 55 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 4 | 0.0 |
Transfection | 2 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Cell Movement/*physiology | 2 | 0.0 |
Dimerization | 4 | 0.0 |
Tumor Necrosis Factor-alpha/*physiology | 2 | 0.0 |
Alleles | 3 | 0.0 |
Animals | 20 | 0.0 |
Cell Division | 3 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Gene Expression | 3 | 0.0 |
Mice | 6 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Peptides/genetics/*physiology | 2 | 16.0 |
RNA, Messenger | 2 | 0.0 |
Sequence Analysis, DNA | 4 | 0.0 |
In Situ Hybridization | 7 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 16 | 0.0 |
Comparative Study | 7 | 0.0 |
English Abstract | 2 | 0.0 |
Goblet Cells/metabolism | 2 | 40.0 |
Protein Biosynthesis | 3 | 0.0 |
Cell Movement/drug effects | 3 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Peptides/*pharmacology | 2 | 0.0 |
Blotting, Western | 3 | 0.0 |
Immunohistochemistry | 13 | 0.0 |
Proteins/*analysis | 2 | 1.0 |
Swine | 3 | 0.0 |
Cell Differentiation | 4 | 0.0 |
Growth Substances/*metabolism | 7 | 4.0 |
Peptides/*metabolism | 17 | 8.0 |
Phenotype | 2 | 0.0 |
Case-Control Studies | 3 | 0.0 |
Chronic Disease | 2 | 0.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Adult | 13 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Female | 19 | 0.0 |
Gastric Juice/*chemistry | 2 | 33.0 |
Glycosylation | 2 | 0.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Male | 19 | 0.0 |
Proteins/analysis | 2 | 1.0 |
Genes, Structural/*genetics | 2 | 0.0 |
Growth Substances/*genetics | 7 | 6.0 |
Peptides/*genetics | 8 | 8.0 |
Promoter Regions (Genetics) | 4 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Cysteine/chemistry | 3 | 2.0 |
Models, Molecular | 3 | 0.0 |
Peptides/chemistry | 2 | 0.0 |
Solutions | 2 | 1.0 |
Metaplasia | 3 | 3.0 |
Peptides/*genetics/metabolism | 5 | 17.0 |
Anti-Inflammatory Agents, Non-Steroidal/*pharmacology | 2 | 1.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Mucins/*metabolism | 10 | 10.0 |
Muscle Proteins/*metabolism | 5 | 11.0 |
RNA, Messenger/metabolism | 9 | 0.0 |
Up-Regulation | 2 | 0.0 |
DNA | 2 | 0.0 |
Genes, Reporter | 5 | 0.0 |
Proteins/*genetics | 3 | 0.0 |
*Digestive Physiology | 3 | 9.0 |
Gastrointestinal Neoplasms/*genetics/metabolism | 2 | 50.0 |
Genes, Reporter/genetics | 2 | 0.0 |
Indomethacin/pharmacology | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Tumor Cells, Cultured | 11 | 0.0 |
Biological Markers/analysis | 2 | 0.0 |
Gastric Mucosa/*chemistry | 3 | 23.0 |
*Helicobacter pylori | 3 | 2.0 |
Immunohistochemistry/methods | 2 | 0.0 |
Mucins/*analysis | 2 | 5.0 |
Peptides/*analysis | 2 | 2.0 |
Chromosome Mapping | 2 | 0.0 |
Neoplasm Proteins/*metabolism | 3 | 0.0 |
Stomach Neoplasms/*metabolism/pathology | 4 | 7.0 |
Binding Sites | 3 | 0.0 |
Transcription Factors/*metabolism | 3 | 0.0 |
Aged | 12 | 0.0 |
Aged, 80 and over | 8 | 0.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
*Protein Biosynthesis | 3 | 0.0 |
Proteins/genetics | 4 | 0.0 |
Rats | 6 | 0.0 |
Cell Transformation, Neoplastic | 2 | 0.0 |
Immunoenzyme Techniques | 5 | 0.0 |
Precancerous Conditions/*metabolism/pathology | 2 | 9.0 |
Proteins/*metabolism | 6 | 0.0 |
Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Growth Substances/*genetics/metabolism | 3 | 13.0 |
Middle Aged | 13 | 0.0 |
Peptides | 2 | 3.0 |
Receptors, Estrogen/*metabolism | 2 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Electrophoretic Mobility Shift Assay | 2 | 0.0 |
Epithelial Cells/metabolism/pathology | 2 | 4.0 |
Tumor Markers, Biological/*metabolism | 2 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Down-Regulation | 2 | 0.0 |
Transcription, Genetic/drug effects | 2 | 0.0 |
*Chromosomes, Human, Pair 21 | 2 | 1.0 |
Gene Frequency | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
*Proteins | 6 | 1.0 |
Structure-Activity Relationship | 2 | 0.0 |
Growth Substances/genetics/metabolism | 3 | 23.0 |
Peptides/genetics/metabolism | 2 | 4.0 |
Adolescent | 3 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Retrospective Studies | 2 | 0.0 |
Transcription Factors/*genetics | 2 | 0.0 |
Peptides/genetics | 3 | 3.0 |
RNA, Messenger/genetics | 2 | 0.0 |
RNA, Neoplasm/genetics | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Rats, Wistar | 2 | 0.0 |
Gastric Mucosa/metabolism/pathology | 2 | 9.0 |
Peptides/genetics/*metabolism | 2 | 6.0 |
Epithelial Cells/metabolism | 2 | 0.0 |
HT29 Cells | 2 | 1.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Growth Substances/*biosynthesis/genetics | 2 | 7.0 |
